Molecular Imaging

PET/CT supports use of infliximab for cardiac sarcoidosis

By Will Morton

FDG-PET/CT imaging has provided new evidence that infliximab is an effective medication for treating cardiac sarcoidosis, a U.K. study has found.

June 11, 2025

Pluvicto shows promise in combination with standard treatments

By AuntMinnieEurope.com staff writers

Novartis has announced that Pluvicto shows promise in patients in an earlier setting.

June 9, 2025

Eckert & Ziegler highlights CE mark for Telix's Illucix

By AuntMinnieEurope.com staff writers

Eckert & Ziegler is highlighting the approval of Telix's prostate cancer PET imaging agent, Illuccix in Germany.

June 6, 2025

Will FAP-targeted theranostics live up to their promise?

By Will Morton

German researchers have reported that fibroblast activation protein (FAP)-targeted theranostics is an emerging technique in the battle against cancer.

June 6, 2025

Deuterium metabolic imaging could help diagnose dementia

By Kate Madden Yee

Deuterium metabolic imaging could offer an alternative to FDG-PET for dementia diagnosis.

May 30, 2025

SIIM: Informatics key to future of theranostics

By Will Morton

Informatics will play an essential role in shaping the future of theranostics, experts say at the Society for Imaging Informatics in Medicine (SIIM) annual meeting

May 26, 2025

Barriers face synthetic amyloid PET image development

By Will Morton

Can synthetic amyloid PET images tell if someone has Alzheimer’s disease? The short answer is not very well, U.K. researchers say.

May 21, 2025

PET scans identify people at early risk for cognitive decline

By Will Morton

Amyloid PET scans in people with early signs of Alzheimer’s can identify those at higher risk of progressing to cognitive decline.

May 6, 2025

German-led team releases findings on Pluvicto therapy

By Will Morton

New evidence supports using SPECT/CT scans along with serum PSA levels to evaluate early patient responses to Pluvicto treatment.

May 2, 2025

Telix's PSMA-PET imaging agent approved in France, Finland

By AuntMinnie.com staff writers

Telix Pharmaceuticals’ prostate cancer PET imaging kit Illuccix has received marketing authorization in France and Finland.

May 1, 2025

AuntMinnieEurope.com Molecular Imaging Insider

By Philip Ward

PET/CT continues to make giant strides in the management of prostate cancer. Radiologists and medical physicists from a top Irish hospital have shared their latest experiences in this area.

April 24, 2025

F-18 PSMA PET-CT proves clinical value in prostate cancer

By Philip Ward

F-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.

April 24, 2025

Page 1 of 120

Next Page